Skip to content

Released Nov 9, 2023, before the open

10-Q filed Nov 13, 2023, 44 days after period end · 0000868278-23-000017

Q3 2023 · 10-Q
Revenue$8.37M−65.4% vs Q3 2022−36.7% vs Q2 2023
Net Income-$5.14MN/M vs Q3 2022N/M vs Q2 2023
EPS Diluted-$0.30N/M vs Q3 2022N/M vs Q2 2023
Gross Profit$2,327,000−80.6%
Operating Income-$6,478,000N/M
Operating Cash Flowderived-$4,654,000N/M
Free Cash Flowderived-$5,322,000N/M
Margins · derived
Gross margin27.8%−21.7 pt vs Q3 2022
Operating margin-77.4%−85.5 pt vs Q3 2022
Net margin-61.5%−65.5 pt vs Q3 2022

What the release said

The release

Same quarter

MetricQ3 2023Q3 2022Q3 2021Q3 2020
Revenue$8.37M$24.20M$9.47M$3.84M
Net Income-$5.14M$968.00K-$3.98M-$408.00K
EPS Diluted-$0.30$0.06-$0.26-$0.04

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR